1μg (R: reducing condition, N: non-reducing condition).
Product Details
Product Details
Product Specification
| Species | Human |
| Accession | Q13641 |
| Amino Acid Sequence | Ser32-Ser355 with hIgG1 Fc Tag at the C-Terminus |
| Expression System | HEK293 |
| Molecular Weight | 50-72kDa (Reducing) |
| Purity | >95% by SDS-PAGE,>90% by HPLC |
| Conjugation | Unconjugated |
| Physical Appearance | Lyophilized Powder |
| Storage Buffer | PBS, pH7.4, 5% trehalose |
| Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
| Stability & Storage |
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃ under sterile conditions after reconstitution. · 1 week, 2 to 8℃ under sterile conditions after reconstitution. · Please avoid repeated freeze-thaw cycles. |
| Reference | 1.Li F, Wang Y, Cao J, Chen Q, Gao Y, Li R, Yuan L. Integrated analysis of genes shared between type 2 diabetes mellitus and osteoporosis. Front Pharmacol. 2024 Jun 20; 15:1388205. |
Background
Trophoblast glycoprotein (TPBG), also known as 5T4, is a therapeutic target for several anticancer agents in clinical development. This is primarily due to its high expression in tumors and low expression in normal adult tissues. The TPBG gene encodes a leucine-rich transmembrane glycoprotein that may play a role in cell adhesion. TPBG is expressed by all types of trophoblasts as early as the ninth week of development.
Picture
Picture
SDS-PAGE
SEC-HPLC
The purity of TPBG/5T4 Fc Chimera Protein, Human is more than 90% determined by SEC-HPLC.
ELISA
Immobilized TPBG/5T4 Fc Chimera Protein, Human (Cat. No.UA016153) at 1.0μg/mL (100μL/well) can bind Naptumomab with EC50 of 22.0-33.0ng/mL.
Immobilized TPBG/5T4 Fc Chimera Protein, Human (Cat. No.UA016153) at 1.0μg/mL (100μL/well) can bind TPBG Recombinant Monoclonal Antibody with EC50 of 0.41-1.70ng/mL.
